The FocAL therapy CONsensus (FALCON): enhancing partial gland ablation for localised prostate cancer-Reference-Cited by-同舟云学术

The FocAL therapy CONsensus (FALCON): enhancing partial gland ablation for localised prostate cancer

Published:2024-04-13 Issue:1 Volume:134 Page:50-53
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Rodríguez‐Sánchez Lara¹^ORCID,Reiter Robert²,Rodríguez Alejandro³^ORCID,Emberton Mark⁴^ORCID,de Reijke Theo⁵,Compérat Eva M.⁶,Bossi Alberto⁷,Sanchez‐Salas Rafael⁸

Affiliation:

1. Urology Department Institut Mutualiste Montsouris Paris France

2. Department of Urology, David Geffen School of Medicine University of California Los Angeles Los Angeles California USA

3. Department of Urology Atrium Health Wake Forest Baptist Medical Center Winston Salem North Carolina USA

4. Division of Surgery and Interventional Science University College London London UK

5. Amsterdam UMC, department of Urology University of Amsterdam Amsterdam The Netherlands

6. Department of Pathology Medical University of Vienna, General Hospital of Vienna Vienna Austria

7. Genitourinary Oncology Prostate Brachytherapy Unit, Gustave Roussy Paris France

8. Department of Surgery, Division of Urology McGill University Montreal Quebec Canada

Publisher

Wiley

Reference6 articles.

1. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years?

2. Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?

3. Delphi methodology in healthcare research: How to decide its appropriateness

4. COMET.Initiative. DelphiManager. Available at:https://www.comet‐initiative.org/delphimanager/[Accessed November 28 2023].

5. Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer